ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph Alex
Levent Guvendik
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alex, J.
Right arrow Articles by Guvendik, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alex, J.
Right arrow Articles by Guvendik, L.
Related Collections
Right arrow Electrophysiology - arrhythmias

Ann Thorac Surg 2005;79:517-520
© 2005 The Society of Thoracic Surgeons


Original article: Cardiovascular

Evaluation of Ventral Cardiac Denervation As a Prophylaxis Against Atrial Fibrillation After Coronary Artery Bypass Grafting

Joseph Alex, MD, MRCS*, Levent Guvendik, MD, FRCS, FETCS

Department of Cardiothoracic Surgery, Castle Hill Hospital, Hull, United Kingdom

Accepted for publication August 4, 2004.

* Address reprint requests to Dr Alex, The Cottage, Main Road, Covenham, St Bartholomew, Louth, LN11 0PF, UK (E-mail: mrjosephalex{at}yahoo.co.uk).

BACKGROUND: To evaluate the efficacy of ventral cardiac denervation as a prophylaxis against post-coronary artery bypass grafting (CABG) atrial fibrillation (AF).

METHODS: Seventy consecutive patients who underwent CABG (group A) were compared to 70 consecutive subsequent patients who underwent CABG + ventral cardiac denervation (group B). Both groups were well-matched for age, gender, disease severity, LV function, Euro scores, Parsonnet scores, preoperative ß-blockers, Ca-channel blockers, digoxin, and angiotensin converting enzyme inhibitors. The same cardioplegia, bypass, and operation techniques were used in all cases. Denervation before initiating bypass increased operation time by approximately 5 minutes. Heart rate and rhythm were monitored by continuous telemetry until postoperative day 5 and then 4- hourly until discharge.

RESULTS: The cross-clamp time (p = 0.6), bypass time (p = 0.1), number of grafts (p = 0.9), inotrope usage (p = 0.4), reexploration rate (p = 1), postoperative myocardial infarction (none in either group), blood loss (p = 0.7), and length of stay (p = 0.8) were comparable in both groups. There was no significant difference in the incidence of AF; 34% in group A versus 29% in group B (p = 0.3).

CONCLUSIONS: Ventral cardiac denervation failed to significantly reduce the incidence of AF following coronary revascularization in our study.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Onorati, A. Curcio, G. Santarpino, D. Torella, P. Mastroroberto, L. Tucci, C. Indolfi, and A. Renzulli
Routine ganglionic plexi ablation during Maze procedure improves hospital and early follow-up results of mitral surgery.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 408 - 418.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Dunning, T. Treasure, M. Versteegh, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 852 - 872.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.